Table 1.
Drug | MICa (μg/ml) for A. hydrophila isolate (resistance phenotype) |
|||
---|---|---|---|---|
AH1 | AH2 | AH3 | AH4 | |
Ampicillin | ≥32 (R) | ≥32 (R) | ≥32 (R) | ≥32 (R) |
Ampicillin-sulbactam | ≥32 (R) | ≥32 (R) | ≥32 (R) | ≥32 (R) |
Cefazolin | ≥32 (R) | 32 (R) | ≥32 (R) | ≥32 (R) |
Cefepime | ≤0.5 (S) | ≤0.5 (S) | ≤0.5 (S) | ≤0.5 (S) |
Gentamicin | ≤0.5 (S) | ≤0.5 (S) | 1 (S) | ≤0.5 (S) |
Piperacillin-tazobactam | ≤8/2 (S) | ≤8/2 (S) | ≤8/2 (S) | ≤8/2 (S) |
Ciprofloxacin | 4 (R) | 4 (R) | 1 (S) | ≤0.015 (S) |
Levofloxacin | 8 (R) | 4 (I) | ≤2 (S) | ≤2 (S) |
Minocycline | 1 (—)b | ≤0.5 (—)b | 1 (—)b | ≤0.5 (—)b |
Trimethoprim-sulfamethoxazole | ≤1/20 (S) | ≤1/20 (S) | ≥4/80 (R) | ≤1/20 (S) |
A. hydrophila isolates were obtained from the patient's face (AH1), the distraction arm (AH2), the blood tube after leech feeding (AH3), and the leech tank water (AH4). Phenotypes: R, resistant; S, susceptible; I, intermediate.
—, No interpretive criteria.